Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
Journal of Neuroimmunology|May 25, 2010
Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functionsTony Avril, Stéphan Saikali, Elodie Vauleon, et al.The FEBS Journal|December 15, 2017
Regulation of tumor-stroma interactions by the unfolded protein responseJoanna Obacz, Tony Avril, Camila Rubio-Patiño, et al.Journal of Neuro-Oncology|September 28, 2006
Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapyStéphan Saikali, Tony Avril, Brigitte Collet, et al.The FEBS Journal|October 4, 2018
Alterations of EDEM1 functions enhance ATF6 pro-survival signalingAlexandra Papaioannou, Arisa Higa, Gwénaële Jégou, et al.Brain Pathology (Zurich, Switzerland)|July 28, 2011
Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cellsTony Avril, Elodie Vauleon, Abderrahmane Hamlat, et al.Journal of Proteomics|May 9, 2013
Proteomic analysis of glioblastomas: what is the best brain control sample?Jean-Michel Lemée, Emmanuelle Com, Anne Clavreul, et al.Cancer Immunology, Immunotherapy : CII|March 5, 2019
Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patientsVéronique Quillien, Antoine F Carpentier, Alain Gey, et al.BMC Cancer|December 6, 2018
The expression of EMX2 lead to cell cycle arrest in glioblastoma cell lineAnnabelle Monnier, Rachel Boniface, Régis Bouvet, et al.Journal of Proteomics|August 5, 2014
Proteomic analysis underlines the usefulness of both primary adherent and stem-like cell lines for studying proteins involved in human glioblastomaBrigitte Collet, Tony Avril, Marc Aubry, et al.Iscience|October 4, 2021
SARS-CoV-2 integral membrane proteins shape the serological responses of patients with COVID-19Sophie Martin, Christopher Heslan, Gwénaële Jégou, et al.Pageof 6